This 5th edition of the international breast cancer course organized by the Institut Curie offers a comprehensive overview of current topics on clinical and biological aspects of breast cancer. This course brings together internationally renowned experts who will present the latest innovations in the clinical management of breast cancer, on both diagnostic and therapeutic aspects, as well as the latest advances in the understanding of biological mechanisms such as plasticity, tumor heterogeneity or genomics of breast cancer. The focus will be on the latest cutting-edge technologies and innovative approaches, including artificial intelligence and single cell analysis. There will also be a focus on luminal B breast cancers, including lobular carcinomas.
The format of the course is designed to encourage exchanges and to allow students to interact with researchers from the Institut Curie and from several international institutes.
You may register for a virtual attendance.
>> REGISTER HERE <<
Note: If you have already registered in the course using the previous form, you do not need to do it again.
The objectives of the 5th edition of the international breast cancer course are:
- to provide students with an overview of the latest clinical and biological advances in breast cancer
- to encourage exchanges through student presentations and poster sessions
- to allow students to reflect on their careers through the « Research in Pharma » and “Publishing your paper” sessions
- project presentation (3 minutes)
- poster or flash talk (optional)
N/A
There will be a prize delivered for the following two evaluations:
- Participation during the course (questions asked to the speakers)
- Poster or flash talk
You may register for a virtual attendance.
For the on-site attendance, students will be responsible for all costs associated with accommodation and transportation. Food will be provided during the course (lunches + cocktail evening).
35 participants
Selection based on resume and letter of motivation
François-Clément BIDARD - FR
Irène BUVAT - FR
Collectif TRIPLETTES ROSES - FR
Suzette DELALOGE - FR
Silvia FRE - FR
Mathilde HIS - FR
Priscilla KELLY - US
Youlia KIROVA - FR
Caroline MALHAIRE - FR
Eliane PIAGGIO - FR
Yolanda PREZADO - FR
Andy RANKIN - US
Fabien REYAL - FR
Raphaël RODRIGUEZ - FR
Emanuela ROMANO - FR
Meriem SEFTA - FR
Marc-Henri STERN - FR
Dominique STOPPA-LYONNET - FR
Céline VALLOT - FR
Anne VINCENT-SALOMON - FR
Fabrice ANDRÉ - FR
Carlos CALDAS - UK
Patrick DERKSEN - NL
Christine DESMEDT - BE
Jos JONKERS - NL
Guido KROEMER - FR
Diether LAMBRECHTS - BE
Jeffrey POLLARD - UK
Kornelia POLYAK - US
Alain PUISIEUX - FR
Jorge REIS-FILHO - US
Georgios SFLOMOS - CH
Christos SOTIRIOU - BE
Andrew TUTT - UK
Jean-Philippe VERT - FR
Laurence ZITVOGEL - FR
This list of speakers may still change
Anne Vincent-Salomon, Institut Curie, Diagnostic and Theranostic Medicine Division
Fatima Mechta-Grigoriou, Institut Curie, Stress & Cancer Lab
François-Clément Bidard, Institut Curie, PU-PH UVSQ, Circulating Cancer Biomarkers Lab
Anastasia Lanzi, Institut Curie, Breast Cancer Medico-Scientific Program
Anne Vincent-Salomon, Institut Curie, Diagnostic and Theranostic Medicine Division
Fatima Mechta-Grigoriou, Institut Curie, Stress & Cancer Lab
François-Clément Bidard, Institut Curie, PU-PH UVSQ, Circulating Cancer Biomarkers Lab
Anastasia Lanzi, Institut Curie, Breast Cancer Medico-Scientific Program
